Companies similar to ADMIT THERAPEUTICS
Sign up to Download

1-30 of 137,505 results

  • www.admit-therapeutics.com
  • 1
  • 10
ADmit THERAPEUTICS - test for an early AD detection. Alzheimer's disease. DETECTION IN CLINICAL PRACTICE. ADmit Therapeutics, S.L. is a company focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection..
Relevance: 78.76983
  • www.septatherapeutics.com
  • 1
  • 5
Septa Therapeutics Inc. is a biotechnology company devoted exclusively to the development of an effective treatment for Alzheimer's Disease (AD)...
Relevance: 40.628983
  • www.presympto.com
  • 1
  • 1
  • 1
Presympto is a biotechnology company founded to bring to market innovative diagnostic products for neurodegenerative diseases... Alzheimer's disease (AD) cases continue to increase without effective diagnosis and treatment solutions. Today, there is..
Relevance: 39.769375
  • www.identifyalz.com
*In the Aging, Demographics and Memory Study (ADAMS), patients were classified as having cognitive impairment without dementia... What biomarker test can be utilized at the MCI stage specifically to verify amyloid beta accumulation?... Learn about..
Relevance: 39.18071
  • www.t3dtherapeutics.com
  • 1
  • 1
  • 19
T3D Therapeutics, Inc. was founded in 2013 to challenge the prevailing thinking over the last two decades in the development of solutions to effectively treat Alzheimer's disease. Our mission is to develop a ground-breaking, disease-modifying, new..
Relevance: 38.67319
  • www.predemtecdx.com
  • 1
  • 3
  • 4
Our company focuses on research, development and manufacture of a blood-based diagnostic procedure for Alzheimer's Disease... Our goal is to make the early and reliable diagnosis of AD a reality with the use of a simple blood test... Predemtec DX..
Relevance: 38.64287
  • www.addp.eu
  • 2
  • 1
AD Detect and Prevent holds webinar on the potential of digital tools for improving the detection of Alzheimer's disease..
Relevance: 38.134346
  • aidea.azurewebsites.net
  • 1
Alzheimer's disease (AD) is a progressive neurodegenerative disease where the patient can progress from preclinical AD to mild cognitive impairment (MCI), and subsequently mild, moderate, or severe dementia. Identification of patients with MCI helps..
Relevance: 36.828407
  • www.retispec.com
  • 1
  • 19
RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye... RetiSpec believes a better future for Alzheimer's starts with the ability to diagnose it. Our mission..
Relevance: 36.189648
  • aactools.uahs.arizona.edu
The ADRC Data Explorer is a project of the Arizona Alzheimer's Consortium (AAC). The Arizona Alzheimer's Consortium is the nation's leading model of statewide collaboration in Alzheimer's disease research. Established in 1998, the Consortium..
Relevance: 35.94823
  • aby-bio.com
  • 2
  • 1
  • 12
Neurodegenerative diseases demand robust diagnostic and therapeutic solutions. At Abyssinia we're transforming the world's understanding of Alzheimer's Disease, from diagnostic assays with the potential for early detection, to treatment paradigms..
Relevance: 35.340916
  • www.aestaspharma.com
  • 1
  • 2
Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer's disease when clinical signs are not yet pronounced...
Relevance: 35.272263
  • acumenpharm.com
  • 1
  • 1
  • 57
Acumen is leveraging decades of learnings to deliver treatments FOR the benefit of everyone impacted by this devastating disease... At Acumen, we are singularly focused on the development of targeted therapies for Alzheimer's disease, a condition..
Relevance: 34.460564
  • brainstorm-cell.com
  • 1
  • 3
  • 18
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.....
Relevance: 33.943428
  • gismotherapeutics.com
  • 1
  • 1
  • 7
Gismo Therapeutics Inc. is a biotech start-up company targeting fundamental biochemical processes that are at the root cause of Alzheimer's and Parkinson's Disease pathogenesis. The company has been awarded several prestigious research grants to..
Relevance: 33.86424
  • www.durintechnologies.com
  • 1
  • 1
  • 5
Durin Technologies Inc. is a New Jersey-based company developing diagnostic tests for early detection of some of the more pervasive and progressive neurodegenerative diseases. The company was founded by Drs. Robert Nagele and Benjamin Belinka in 2010..
Relevance: 33.608097
  • procogny.com
  • 1
  • 1
Led by Founder and CEO Doug Ethell, Leucadia Therapeutics has looked at Alzheimer's disease with new eyes. We have assembled an amazing team of dedicated professionals who are focused on CURING Alzheimer's disease...
Relevance: 33.444176
  • www.jaltherapeutics.com
  • 1
  • 1
JAL Therapeutics is a preclinical stage life sciences company, focused on drug development for the treatment of Alzheimer's disease and other chronic conditions... JAL's unique approach centers on a mechanism of action that's designed to activate..
Relevance: 33.358894
  • www.adrc.wisc.edu
  • 34
  • 2
  • 170
The Wisconsin ADRC is focused primarily on improving early detection of Alzheimer's disease, identifying risk and protective factors, and finding ways to delay onset and progression. Much of the center's science is based on a wealth of information..
Relevance: 33.02984
  • rosettatherapeutics.com
  • 1
  • 4
. Rosetta Therapeutics is developing first-in-class disease-modifying, small molecule therapeutics for the treatment of neurodegenerative disease with an immediate focus on Parkinson's disease (PD)... We are developing new molecular matter as leads..
Relevance: 32.525414
  • www.adcs.org
  • 1
  • 1
  • 13
(NIA) and the University of California, San Diego. The ADCS is a major initiative for Alzheimer's disease (AD) clinical studies in the Federal Government, addressing treatments for both cognitive and behavioral symptoms. The ADCS is part of the NIA..
Relevance: 32.297024
  • www.tokeya.de
  • 6
  • 1
  • 6
Tokeya is a young company from Würzburg (founded in July 2017) and provider of products and services in the fields of... The diagnostic software tools developed by Tokeya aim at early, preclinical detection of the presence of Alzheimer's disease..
Relevance: 32.26637
  • www.rajeshamin.com
  • 9
  • 1
  • 8
Metabolic Therapeutics and the Amin Lab seeks to translate their understanding of cellular metabolism into novel effective therapeutics for diseases associated with metabolic dysfunction. We develop novel chemical tools for better understanding how..
Relevance: 32.181152
  • www.stratastem.com
  • 1
  • 3
StrataStem is an innovative spin-out biotech working at the forefront of Alzheimer's disease (AD) research and is developing intelligent phenotype-genotype (iPG) drug screening platforms to identify appropriate therapeutics for AD. We use induced..
Relevance: 32.136402
  • dian.wustl.edu
  • 3
  • 2
  • 2
The DIAN-TU, the clinical research arm of DIAN, is an international partnership dedicated to designing and managing interventional therapeutic trials for individuals with and at risk of DIAD... DIAN is an international research partnership involving..
Relevance: 31.683495
  • www.remegenix.com
  • 3
  • 5
RemeGenix is developing its lead drug candidate MoBA as a disease modifying treatment for Alzheimer's disease (AD)... RemeGenix is dedicated to the development of disease modifying drugs that can be used to treat Alzheimer's and technology platforms..
Relevance: 31.247803
  • www.cognitotx.com
  • 2
  • 1
  • 12
Cognito is developing novel and innovative therapeutics designed to potentially improve the lives of patients living with neurodegenerative disease... Cognito is developing disease-modifying treatments to revive the health and well-being of patients..
Relevance: 30.933607
  • health.questdiagnostics.com
Leading the conversation around Alzheimer's research and the latest testing innovations... Hear from Dr Stephen Salloway and Dr Michael Racke as they discuss the current opportunities and challenges in diagnosing Alzheimer's Disease, the emerging..
Relevance: 30.610308
  • ai4ad.org
  • 2
  • 9
  • 32
Our team of experienced PIs will coordinate efforts across the U.S. to create these large-scale data analytic tools. Our MPI team and 6 Core Leads have decades of experience working together and with the AD community in pioneering machine learning..
Relevance: 30.47229
  • brainsciences.scot
  • 1
  • 17
Scottish Brain Sciences is a research organisation dedicated to early detection and treatment of Alzheimer's disease and similar conditions. We deliver clinical trials of new diagnostics and medicines that slow or stop disease progression.....
Relevance: 30.458311